Dr. Rei-I Chin, resident physician, has received a Seed Grant for her research from the American College of Radiation Oncology (ACRO). Dr. Chin’s research aims to compare clinical outcomes and cost-effectiveness of patients with unresectable HCC treated with dose-escalated Y-90 radioembolization vs. MR-guided SBRT.